Jean-Baptiste Duval

Director

Jean-Baptiste Duval

Director

Profile

Jean-Baptiste joined CFI with 20 years of experience in Licensing and M&A.

He started his career in Biotech in 2000 before joining a large organization in F&B, Energy and Space Industry in Europe and Asia. From 2010, he has successfully managed M&A and Business Development for a large German Healthcare Group and an international French Pharmaceutical Group, as well as spending 3 years assisting a Chinese Biotech company in Shanghai.

Sector focus

Healthcare & Life Sciences

Our latest transactions

See all transactions

Healthcare & Life Sciences

has been acquired by

Transaction details

Polish dietary supplement company MyBestPharm has been acquired by the French Urgo Group

has acquired

Transaction details

Omnes Médical, a network of medical device distribution companies, has acquired LVM88, LVM52, Prest Equip, and LVM14, a group specializing in healthcare services

has been acquired by

Transaction details

HDAA, an Australian audit and assessment agency, has been acquired by Bureau Veritas, a world leading company specialising in testing, inspection and certification

has sold

Transaction details

L’Institut Mérieux has sold its subsidiary ABL Lyon (renamed to Active Biomarkers), an integrated bioanalytical laboratory with biomarker and cell-based assay testing capabilities, to Turenne Santé

Jean-Baptiste Duval